Recent changes in the GMS contract for 2010-11 have led to some practices losing potential income under the Quality and Outcomes Framework. At its inception, adjusted disease prevalence factor gave some protection to practices with low disease prevalence by utilising a square root formula in its calculation. The revised payment system saw the removal of the square root formula for 2009/10 and the subsequent removal of the 5% cut-off arrangements for 2010/11.
The recent re-allocation of points has also led to a reduction in potential income for the clinical domains of the QoF. It is therefore even more important that practice disease registers are accurate and up to date.
The table below explains how the difference in prevalence affects the value of a point. The difference made by the lower number of points available can also be clearly seen.
Based on national prevalence of CHD of 3.4%
| Practice | CHD Prevalence | QoF point value 09/10 | Max Domain Income ** | QoF point Value 10/11 | Max Domain Income * |
| A | 3.0% | £106.83 | £9,295 | £112.70 | £8,565.41 |
| B | 3.4% | £128.20 | £11,154 | £130.51 | £9,918.76 |
| C | 4.0% | £142.44 | £12,393 | £151.34 | £11,502.12 |
Oberoi Consulting has worked with many practices to support disease register validation since the inception of the GMS contract. The evidence to date illustrates that there are often inaccuracies in data which then impacts on prevalence, patient care and QoF income.
The calculator will automatically create a graph (such as shown below), showing the practice prevalence against the latest UK national average.
The Summary page of the calculator (example shown below) will show how the current prevalence is reflected in potential income. By changing the number of patients on the various disease registers the practice can easily see how changes will effect income.
By concentrating on those areas with most potential for growth (ie. those areas where the practice prevalence is significantly lower than the UK national average prevalence), the practice are able to work through the disease areas in priority order.
The cost of the calculator is £50 + VAT at the current rate.
Order the Oberoi Prevalence Calculator here
For further information about our Disease Register Validation services, or to discuss how they can be tailored to meet your specific requirements, please feel free to contact us.
Click here to view the Clinical Commissioning Group DRV Case Study